Purpose: The off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for the treatment of mandibular bone defects was evaluated in 5 patients. The rhBMP-2 was used as an alternative to autogenous bone grafting.
Patients And Methods: A total of 5 patients had mandibular defects reconstructed with rhBMP-2, 1.